Table 2.
The baseline clinical characteristics of CAD patients. Statistical comparisons among the three groups were performed by ANOVA. Values are means ± s.d. CAD, coronary artery disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TCH, total cholesterol; TG, total triglyceride; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol.
| controls | CAD | CAD recovery | ||
|---|---|---|---|---|
| (N = 16) | (N = 28) | (N = 20) | ANOVA | |
| age (years) | 55.13 ± 13.68 | 55.79 ± 10.57 | 59.25 ± 8.95 | 0.346 |
| BMI (kg m−2) | 21.99 ± 1.78 | 24.56 ± 2.49 | 25.17 ± 2.70 | <0.001 |
| SBP (mmHg) | 117.29 ± 16.02 | 133.18 ± 17.19 | 125.90 ± 17.80 | <0.001 |
| DBP (mmHg) | 73.07 ± 10.90 | 79.32 ± 10.08 | 71.4 ± 9.54 | 0.02 |
| FBG (mmol l−1) | 5.04 ± 0.53 | 5.96 ± 2.96 | 5.47 ± 1.42 | 0.423 |
| TCH (mmol l−1) | 4.31 ± 1.63 | 3.86 ± 1.25 | 4.24 ± 0.79 | 0.413 |
| TG (mmol l−1) | 1.74 ± 1.08 | 1.69 ± 0.77 | 2.32 ± 1.91 | 0.224 |
| HDL-c (mmol l−1) | 1.42 ± 0.33 | 1.08 ± 0.41 | 1.02 ± 0.23 | <0.001 |
| LDL-c (mmol l−1) | 2.80 ± 0.19 | 2.34 ± 0.96 | 2.35 ± 0.73 | 0.195 |